Keyphrases
Neurotrophic Keratopathy
100%
Epithelial Damage
33%
Nerve Pathology
33%
Trophic Function
33%
Antibiotics
16%
Anesthesia
16%
High Risk
16%
Heparan Sulfate
16%
Enzymatic Degradation
16%
Quality of Life
16%
Recombinant
16%
Epithelium
16%
Surgical Intervention
16%
Nerve Growth Factor
16%
Medical Management
16%
Antisense Oligonucleotides
16%
Attrition
16%
Anti-inflammatory Agents
16%
Sensory Nerves
16%
Biopolymers
16%
Connexin 43 (Cx43)
16%
Non-healing
16%
Eye Conditions
16%
Patient-specific Therapy
16%
Failure Risk
16%
Perforation
16%
Antiprotease
16%
Human Use
16%
Ocular Surface
16%
Amniotic Membrane
16%
Corneal Sensation
16%
Botulinum Neurotoxin (BoNT)
16%
Coenzyme Q10
16%
Contact Lens
16%
Artificial Tears
16%
Corneal Epitheliopathy
16%
Systemic Conditions
16%
Nociceptor
16%
Corneal Surgery
16%
Allodynia
16%
Tear Film
16%
Lubricating Agent
16%
Punctal Plugs
16%
Tarsorrhaphy
16%
Aberrant Regeneration
16%
Hyperesthesia
16%
Cenegermin
16%
Eyelid Closure
16%
Conjunctival Flap
16%
Medicine and Dentistry
Neurotrophic Keratopathy
100%
Sensation
33%
Skin Defect
33%
Quality of Life
16%
Venous Ulcer
16%
Antiinflammatory Agent
16%
Lid
16%
Stroma
16%
Proteinase Inhibitor
16%
Biopolymer
16%
Biological Product
16%
Lubricating Agent
16%
Heparan Sulfate
16%
Regeneration
16%
Ocular Surface
16%
Amnion
16%
Clostridium Botulinum Type A
16%
Contact Lens
16%
Artificial Tear
16%
Connexin 43
16%
Tear Film
16%
Nociceptor
16%
Corneal Surgery
16%
Allodynia
16%
Antibiotics
16%
Recombinant Nerve Growth Factor
16%
Cenegermin
16%
Tarsorrhaphy
16%
Antisense Oligonucleotide
16%
Hyperesthesia
16%
Conjunctival Flap
16%
Punctal Plug
16%
Coenzyme Q10
16%
Surgery
16%